Latest Articles
First patient dosed in phase 3 trial evaluating ENHERTU in endometrial cancer By Investing.com - Investing.com South Africa
First patient dosed in phase 3 trial evaluating ENHERTU in endometrial cancer By Investing.com Investing.com South Africa
Published: Dec. 22, 2025, 8:15 a.m.
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer - The AI Journal
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer The AI Journal
Published: Dec. 22, 2025, 7:31 a.m.
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer - itemonline.com
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer itemonline.com
Published: Dec. 22, 2025, 7:30 a.m.
Jessie J says going vegan helped ease her endometriosis symptoms – here’s what changed - Women's Health
Jessie J says going vegan helped ease her endometriosis symptoms – here’s what changed Women's Health
Published: Dec. 22, 2025, 6:01 a.m.
Fertility preservation in endometriosis: current strategies and outcomes.
Endometriosis is a frequent chronic estrogen-dependent condition that can significantly impair fertility and reduce the quality of life in affected individuals. Women with endometriosis face a 30-50% risk of infertility. …
Published: Dec. 22, 2025, midnight
Systematic analyses uncover endocrine-disrupting chemical-responsive genes linked to endometriosis.
Endometriosis is a chronic, estrogen-dependent disorder influenced by both genetic and environmental factors, including endocrine-disrupting chemicals (EDCs). This study aimed to identify EDC-responsive genes contributing to endometriosis risk by integrating …
Published: Dec. 22, 2025, midnight
New Combination Therapy Shows Promise for pMMR Advanced Endometrial Cancer in Phase Ib/II Trial - geneonline.com
New Combination Therapy Shows Promise for pMMR Advanced Endometrial Cancer in Phase Ib/II Trial geneonline.com
Published: Dec. 21, 2025, 12:34 p.m.
Adenosarcoma of the uterine cervix – a novel case report and review of the literature - Termedia
Adenosarcoma of the uterine cervix – a novel case report and review of the literature Termedia
Published: Dec. 21, 2025, 8:41 a.m.
Why OrthoPediatrics Corp. stock appeals to dividend seekers - Market Risk Analysis & AI Based Buy and Sell Signals - Улправда
Why OrthoPediatrics Corp. stock appeals to dividend seekers - Market Risk Analysis & AI Based Buy and Sell Signals Улправда
Published: Dec. 20, 2025, 10:57 a.m.
Why OrthoPediatrics Corp. stock appeals to dividend seekers - Market Risk Analysis & AI Based Buy and Sell Signals - ulpravda.ru
Why OrthoPediatrics Corp. stock appeals to dividend seekers - Market Risk Analysis & AI Based Buy and Sell Signals ulpravda.ru
Published: Dec. 20, 2025, 10:57 a.m.
Link copied to clipboard!